Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

October 20, 2018

Study Completion Date

April 21, 2019

Conditions
Oral Ulcer
Interventions
OTHER

Probiotics

Sixty adult (group A) and 60 children patients (group B) with diagnosis of minor RAS were included. Both groups were divided into two subgroups, AI and BI (test subgroups) and AII and BII (control subgroups). For test subgroups, probiotic lozenges were consecutively administered twice daily, for five days. The size and pain level of ulcers were recorded on treatment days 0, 3 and 5. The outbreak frequency of RAS within 6 months was investigated for all subgroups.

DRUG

Oracure oral gel

Sixty adult (group A) and 60 children patients (group B) with diagnosis of minor RAS were included. Both groups were divided into two subgroups, AI and BI (test subgroups) and AII and BII (control subgroups). For control subgroups, oracure gel were consecutively applied twice daily, for five days. The size and pain level of ulcers were recorded on treatment days 0, 3 and 5. The outbreak frequency of RAS within 6 months was investigated for all subgroups.

All Listed Sponsors
lead

Reham Lotfy Aggour

OTHER

NCT04383236 - Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis | Biotech Hunter | Biotech Hunter